ArticleThe American journal of medicine2022

Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity.

Mayra Tisminetzky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.